L, P., A, C., E, B., A, J., S, B., S, P., . . . F, A. (2017). Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm. Haematologica, 102(11), 1861. https://doi.org/10.3324/haematol.2017.169326
Chicago Style (17th ed.) CitationL, Philippe, et al. "Bortezomib as a New Therapeutic Approach for Blastic Plasmacytoid Dendritic Cell Neoplasm." Haematologica 102, no. 11 (2017): 1861. https://doi.org/10.3324/haematol.2017.169326.
MLA (9th ed.) CitationL, Philippe, et al. "Bortezomib as a New Therapeutic Approach for Blastic Plasmacytoid Dendritic Cell Neoplasm." Haematologica, vol. 102, no. 11, 2017, p. 1861, https://doi.org/10.3324/haematol.2017.169326.
Warning: These citations may not always be 100% accurate.